In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in ovarian cancer, uterine cancer, cervical cancer, multiple myeloma, and head and neck cancer. Read More >>
gynecologic cancers
August 17, 2023 · Brielle Gregory Collins, ASCO staff
July 24, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the July 2023 session of the ASCO Plenary Series, which highlights a study evaluating a potential maintenance therapy option for people with advanced or recurrent TP53 wild-type endometrial cancer. Read More >>
June 3, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. A study that will be presented today explores combining immunotherapy and targeted therapy to reduce the risk of death and recurrence for people with advanced ovarian cancer. Read More >>
June 2, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. This research explores using less extensive surgery for cervical cancer and using targeted therapy to reduce the risk of breast cancer recurrence. Read More >>
January 4, 2023 · Kate Ruder
When considering hormone replacement therapy to manage symptoms of menopause, you may wonder whether it can affect your risk for cancer. Here, review an explanation of different types of hormone replacement therapies, how they work, and what research says about cancer risk. Read More >>